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Abstract
Introduction: Available data on the possible association 
between Helicobacter pylori (H. pylori) infection and 
diabetes mellitus (DM) are contradictory. The prevalence 
of cytotoxin associated gene product A (cagA) positive 
H. pylori is high in Egypt. This study aims to examine its 
association with type 2 DM, and its effect on glycemic 
control and the occurrence of microalbuminuria.
Methods: The study involved 98 dyspeptic type 2 
diabetic patients and 102 dyspeptic non-diabetic subjects 
who underwent upper gastrointestinal tract endoscopy 
in Zagazig university hospital. H. pylori infection was 
diagnosed by histopathology and/or culture. The presence 
of cagA positive strains was confirmed by polymerase 
chain reaction (PCR) and gel electrophoresis. Fasting 
blood sugar (FBS), glycosylated hemoglobin (HbA1c) and 
urinary albumin excretion ratio (UAER) were compared 
between infected and non-infected diabetic patients.
Results: Diabetic patients had similar age and gender 
distribution but significantly higher body mass index 
(BMI) compared to controls. The prevalence of H. pylori 
infection (54.1% versus 56.9%, P = 0.3) and the prevalence 
of cagA positive H. pylori strains (40.8% versus 36.3%, 
P =0.1) were not significantly different between the two 
groups. Diabetic patients infected with cagA positive 
H. pylori strains had higher mean FBS (199±22 versus 
163±20, P=0.00), higher mean HbA1c (8.6±0.8 versus 
6.3±0.8, P=0.00) and higher rate of microalbuminuria 
(67.5% versus 10.3%, P=0.00) than non infected diabetic 
patients.
Conclusion: H. pylori infection with cagA positive 
strains was similarly common in dyspeptic diabetic 
patients and controls. It was associated with poorer 
glycemic control and higher rates of microalbuminuria in 
diabetic subjects. 
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Introduction
Helicobacter pylori is a gram-negative microaerophilic 
spiral bacterium that inhabits the mucous layer covering 
gastric epithelial cells. It is a major cause of chronic 
superficial gastritis, duodenal or gastric ulceration, 
and gastric adenocarcinoma. Many strains of H. pylori 
produce an immunogenic high molecular weight protein 
called cytotoxin associated gene product A (cagA). 
Infection with such strains can be detected by a simple 
serological test for anti-cagA antibodies. The ability to 
induce cytokines differs among H. pylori strains; cagA 
positive strains induce various kinds of cytokines and 
may cause severe inflammation, whereas cagA negative 
strains induce IL-8 and IL-1 beta only weakly and may 
cause only mild inflammation [1]. H. pylori strains which 
express cagA are more often associated with peptic 
ulceration and gastric adenocarcinoma than are cagA 
negative strains [2]. 
Infection by cagA positive H. pylori strains was recently 
reported to have an association with increased intima/
media thickness and poorer short-term outcome in 
atherosclerotic stroke patients [3]. H. pylori eradication 
therapy was also reported to improve the platelet 
count in H. pylori positive patients with idiopathic 
thrombocytopenic purpura (ITP) [4]. These associations 
may be due to cytokine induction by H. pylori or to 
antigen mimicry between it and host antigens.  
In patients with diabetes mellitus (DM), chronic infections 
are frequent and severe, due to the impairment of their 
immune status. However, data on the prevalence of H. 
pylori infection in diabetics are scanty and contradictory. 
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Community based surveys gave conflicting results about 
the prevalence of gastro-intestinal (GI) tract symptoms in 
persons with or without DM [5, 6]. Some studies reported 
no difference in H. pylori infection rates between diabetic 
patients and controls [7-11], while other studies reported 
a higher rate of H. pylori infection in diabetic patients 
[12-15].
The prevalence of cagA positive H. pylori is common in 
Egypt and is related to the clinical presentation, being 
lowest in asymptomatic controls (11.1%) and increasingly 
prevalent in non-ulcer dyspepsia (40%), peptic ulcer 
(66.7%), and gastric cancer (89%) [16].
This study was performed to examine the possible 
relationship between infections by cagA positive H. 
pylori strains, occurrence of microalbuminuria and 
reduced glycemic control in type 2 diabetic patients.
Methods
This is a case-control study conducted in Zagazig 
University Hospital. It involved 102 consecutive 
dyspeptic non-diabetic subjects (58 males, 44 females, 
mean age 46±6.2 years) as controls and 98 dyspeptic 
type 2 diabetic patients (53 males, 45 females, mean 
age 45±5.4 years) as cases. All subjects gave informed 
consent before participation. Dyspeptic symptoms were 
defined by the presence of epigastric pain, bloating, 
nausea, vomiting and early satiety. Subjects were 
excluded if they had ischemic chest pain, previous stroke, 
decompensated heart failure, connective tissue disorders, 
neoplastic diseases, hematological diseases, renal 
impairment, history of gastric surgery, cholecystectomy 
or peptic ulcer, or previous H. pylori eradication. We 
also excluded patients who were on non steroidal 
anti-inflammatory drugs, antibiotics, H2 blocker, or 
proton pump inhibitors within two months prior to the 
procedure. Investigations included fasting blood glucose, 
glycosylated hemoglobin (HbA1c), and 24 hours urinary 
albumin excretion rate (UAER). UAER was measured 
using a solid-phase enzyme-linked immunosorbent 
assay (ELISA) (Micro Albumin Quantitative test; DRG 
International, Inc., USA) with a lowest detection limit of 
1 mcg/ml. Microalbuminuria was defined by an UAER 
of 30–299 mg/24 hours. 
All subjects underwent endoscopy after overnight fasting 
using fiber-optic endoscope (ZIF XQ230; Olympus, 
Center Valley, PA) and two biopsies were taken from 
each subject for bacterial isolation; the first biopsy was 
taken about 2 cm proximal to the pylorus and the second 
biopsy was taken from the corpus of the stomach. The 
specimens were transported to the laboratory in 0.2 ml of 
20% glucose broth (BioMerieux) in sterile screw-capped 
tubes at 4°C within 2 hours. Before culture, the specimens 
were grounded and homogenized with a sterile mortar 
and pestle in 1ml of saline. The biopsy homogenate was 
placed onto a Columbia blood agar plate supplemented 
with trimethoprim, vancomycin, and amphotericin B. The 
plates were incubated under microaerophilic conditions; 
5% O2, 7.5% CO2, 7.5% H2, and 80% N2 using 
CampyPak microaerophilic system envelopes (Columbia 
Diagnostics, Springfield, VA) at 37°C for up to 10 days. 
Plates were checked every other day for growth. On day 
5, plates without obvious growth were subcultured onto 
Columbia blood agar plates to promote growth of lightly 
growing colonies that may have been missed visually. 
All colonies with macroscopic appearance suggesting 
H. pylori (small, circular and smooth) were tested by 
Gram-stain, oxidase, catalase, and urease tests to confirm 
identification [17]. 
The H. pylori infection was considered positive if culture 
and/or histopathological examination and rapid urease test 
were positive. All the isolated H. pylori were suspended 
in 2 ml of tryptone soy broth medium containing 20% 
(vol/vol) glycerol and kept frozen at -70°C until DNA 
extraction was performed [18]. To remove culture from 
frozen stock, vial was placed in an alcohol-dry ice bath. 
A small amount of frozen culture was scraped into tip of a 
Pasteur pipette. Columbia blood agar plate was inoculated. 
5 ml Brucella broth was inoculated with H. pylori 
isolates and put in CO2 incubator under microaerophilic 
condition for 2-3 days. 1.5 ml of the culture was spun in 
a microcentrifuge for 2 minutes at 13.000 rpm to obtain a 
compact pellet. The supernatant was discarded. The DNA 
was extracted from the pellets by use of the QIAamp 
DNA kit (QIAGEN, Hilden, Germany) according to the 
manufacturer’s recommendations and DNA stored at 
-20°C until analysis. DNA extraction negative controls 
were performed in parallel by including sterile tubes 
without samples to check for contamination of the DNA 
extraction reagents. Polymerase Chain Reaction (PCR) 
was performed for detection of cagA gene. It was done 
by using a primer pair: (forward: 5´ AAT ACA CCA ACG 
CCT CCA AG 3´, reverse: 5´TTG TTG CCG CTT TTG 
CTC TC 3´). PCR was carried out in a 25 μL volume 
in thermal cycler (Perkin Elmer-Cetus, USA). Cycling 
conditions were as followed: initial denaturation at 95°C 
for 5 minutes, followed by 34 cycles of denaturation 
at 94°C for 1 minute, annealing at 53°C for 1 minute, 
and extension at 94°C for 1 minute. A final extension 
cycle was extended to 5 minutes at 72°C. A 400-base 
pair amplification product was detected on 2% agarose 
gel. Ten μl volumes of each PCR mixture were mixed 
with the two µl gel loading buffer and subjected to gel 
electrophoresis (2% agarose). 
Statistical analysis was performed using SPSS version 
13. Proportions were compared using Chi square test 
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while means were compared using student-t test. P value 
< 0.05 was considered significant.
Results
Diabetic patients and non-diabetic subjects had similar 
age and gender distribution, but diabetic subjects 
had significantly higher body mass index (BMI). The 
prevalence of H. pylori infection was not different 
between the two groups (54.1% versus 56.9%, P = 0.3). 
The prevalence of cagA positive H. pylori infection was 
not different between diabetic and non-diabetic subjects 
(40.8% versus 36.3%, P =0.1) (Table 1).
Indices of glycemic control were significantly different 
between diabetic patients infected with cagA positive H. 
pylori strains and diabetic patients who tested negative 
for these strains, with the former group having poorer 
glycemic control. Diabetic patients who were infected 
by cagA positive H. pylori strains also had significantly 
higher rates of microalbuminuria (Table 2).
Discussion
There is little and contradictory data about the relationship 
between H. pylori infection and diabetes mellitus. 
Diabetics have impaired cellular and humoral immunity 
that encourage chronic infections, and they often 
have reduced gastrointestinal motility and autonomic 
neuropathy which may enhance bacterial colonization 
and overgrowth. On the other hand, diabetic patients 
often have reduced acid secretion or achlorohydria, and 
may have microangiopathy of gastric mucosa. All these 
factors decrease the chance of growth of H. pylori. 
In this series, we found no difference in the prevalence of 
H. pylori infection or in the prevalence of cagA positive 
strains between dyspeptic diabetic and non-diabetic 
subjects. This is in agreement with previous studies 
reported by Candelli et al [10], Anastasios et al [7], 
Demir et al [8] Xia et al [9], and Ko et al [11]. However, 
other studies reported a higher prevalence of H. pylori 
infection in type 2 diabetic patients in comparison to 
non diabetic subjects [12-15]. This discrepancy between 
results may be attributable to differences in sensitivity 
of methods used to detect infection or to differences in 
selection of control groups and sample sizes. 
The prevalence of microalbuminuria was 30.6% in this 
group of diabetic subjects compared to 21.6% in non-
diabetic subjects, but the difference was not statistically 
significant,  probably due to the small sample size. 
However, diabetic subjects infected with cagA positive 
strains had a markedly higher rate of microalbuminuria 
compared to cagA negative patients (67.5% versus 
10.3%, P=0.00). This association may be related to 
potential cross mimicry between anti-cagA antigens and 
renal antigens, an area that warrants further research. 
Table 1: Demographic and clinical characteristics of dyspeptic subjects with and without type II diabetes mellitus
Clinical and laboratory data Diabetic  
dyspeptic subjects  (n = 98)
Non-diabetic  
dyspeptic subjects ( n = 102)
P value
Age (years), mean ± SD 45.6 ± 5.8 44.9 ± 6.3 0.367
Male gender, number (%) 53 (54.1%) 58 (56.9%) 0.692
BMI (kg/m2), mean ± SD 25.8 ± 3.5 21.5 ± 1.8 0.000
H. pylori infection, number (%) 53 (54.1%) 58 (56.9%) 0.321
Infection with cagA positive strains, number (%) 40 (40.8%) 37 (36.3%) 0.145
Microalbuminuria, number (%) 30 (30.6%) 22 (21.6%) 0.145
Table 2: Indices of glycemic control and prevalence of microalbuminuria among cagA positive and cagA negative diabetic 
patients
Clinical and laboratory data cagA positive  
diabetic patients (n = 40)
cagA negative  
diabetic patients  (n = 58)
P value
Fasting blood glucose (mg/dl), mean ± SD 199 ± 22 163 ± 20 0.000
HBA1c (%), mean ± SD 8.6 ± 0.8 6.3 ± 0.8 0.000
Microalbuminuria, number (%) 27 (67.5%) 6 (10.3%) 0.000
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We found evidence of significantly better glycemic 
control among diabetic subjects without cagA H. pylori 
infection compared to infected diabetics. This effect of 
H. pylori infection was not detected by Demir et al [8], 
but was reported by Fernandini-Paredes et al [19]. 
Aydemir et al used HOMA-IR (homeostasis model 
assessment of insulin resistance) level to assess insulin 
resistance in 36 H. pylori positive and 27 H. pylori 
negative subjects [20]. They found an HOMA-IR level 
of 2.56 ± 1.54 in the H. pylori positive group compared 
to 1.73 ± 1.1 in the H. pylori negative group (P < 0.05). 
These data provided evidence for an association between 
chronic H. pylori infection and insulin resistance. H. pylori 
may induce chronic hyperinsulinemia by decreasing the 
serum concentration of somatostatin [21] which has an 
inhibiting effect on insulin release. The induction of 
cytokines by cagA positive strains may also stimulate 
the secretion of insulin counter-regulatory hormones. 
H. pylori infection was reported to be associated with 
lower fasting plasma glucose concentrations among 
women [22], and the findings of Bégué et al suggest that 
eradication of H. pylori infection in patients with type 1 
diabetes might be associated with better glycemic control 
[23].
Microalbuminuria is an early marker of diabetic 
nephropathy in type 2 DM. We report a significantly and 
markedly higher rate of microalbuminuria among cagA 
positive diabetic patients compared to cagA negative 
patients. This association may be related to the enhanced 
production of cytokines in cagA positive strain infected 
patients. Antigen mimicry between cagA positive strains 
and endothelial cells [24] may trigger immune-mediated 
injury at the level of the glomerulus resulting in albumin 
leakage.
This association warrants further investigations. The 
potential therapeutic advantage of H. pylori eradication 
in the management of DM and its complications remains 
to be determined.
Conclusion
H. pylori infection with cagA positive strains was 
common among this group of dyspeptic diabetic patients 
with no significant difference from controls. Infection 
with cagA positive strains was associated with poorer 
glycemic control and higher rates of microalbuminuria. 
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